Sangamo Therapeutics Inc (SGMO)

Sangamo Therapeutics Inc (SGMO) 財務データ

損益計算書

四半期ごと

*すべての数値は百万単位です

期間終了日	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
期間の長さ	3 か月	3 か月	3 か月	3 か月	3 か月
Revenues	78.27% 2.042	9.398	6.835	157.96	27.23
Operating Expenses	44.65% 64.10	115.81	130.41	139.92	82.62
Benefits Costs and Expenses	44.24% 62.61	112.29	127.61	136.63	303.15
Costs And Expenses	44.24% 62.61	112.29	127.61	136.63	73.19
Operating Income/Loss	41.68% -62.06	-106.41	-123.57	18.03	-55.39
Income/Loss From Continuing Operations Before Tax	41.14% -60.57	-102.89	-120.77	21.33	-275.92
Income Tax Expense/Benefit, Deferred	176.92% -0.14	0.182	-	-	-
Income Tax Expense/Benefit	121.42% -0.272	1.27	-6.264	0.194	0.259
Income/Loss From Continuing Operations After Tax	42.11% -60.30	-104.16	-114.51	21.13	-51.97
Net Income/Loss	42.11% -60.30	-104.16	-114.51	21.13	-51.97
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	99.40% 1.069	177.17	174.32	168.53	3.495
Diluted Average Shares	99.40% 1.069	177.17	174.32	169.18	3.495
Basic Earnings Per Share	42.37% -0.34	-0.59	-0.66	0.13	-0.32
Diluted Earnings Per Share	42.37% -0.34	-0.59	-0.66	0.12	-0.32
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-